Eric Richman - Aug 16, 2021 Form 4/A - Amendment Insider Report for Gain Therapeutics, Inc. (GANX)

Signature
/s/ Trevor Bossi, Attorney-in-Fact
Stock symbol
GANX
Transactions as of
Aug 16, 2021
Transactions value $
$38,716
Form type
4/A - Amendment
Date filed
4/21/2022, 04:50 PM
Date Of Original Report
Aug 17, 2021
Previous filing
Apr 21, 2022
Next filing
Sep 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GANX Common Stock Purchase $38.7K +4.92K +2.32% $7.87 217K Aug 16, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The original Form 4 filed on August 17, 2021 incorrectly listed the transaction code at "M" instead of "P".

Remarks:

On the original Form 4 filed on August 17, 2021, the Reporting Person's relationship the the Issuer omitted listing him as the Chief Executive Officer.